Publisher's Synopsis
The market for pharmaceuticals is undergoing radical change, and one of the most important elements of this change is the growing prominence of over-the-counter products. Changing the status of products from prescription-only to OTC can transfer the cost of buying them from a deficit-laden health authority to the consumer. For the producers and distributors of these products, as well as for suppliers of materials and services to the parmaceutical industry, these changes will have significant effects. Identifying the resulting opportunities and adapting them will present challenges.;This report provides: an analysis of the European pharmaceuticals industry and market; an examination of the actions and policies of the European Union affecting the OTC sector and the pharmaceutical industry as a whole; information on how the market for OTC pharmaceuticals is growing in Europe; an understanding of the dynamic forces influencing the market; detailed studies of the markets for OTC products in Germany, France, the UK, Italy and Spain; information on leading OTC producers, their brands, market shares and strategies; an assessment of the prospects and opportunities.;The information and analysis in this report sets out to help users: position their products advantageously; assess the performance and activities of the competition; exploit the opportuinties in this evolving marketplace; and consider the best options for business development and plan strategies.
